© Genesis Research Services, 2025
It’s hard to believe that a quarter of the year has already passed! In this newsletter, we introduce you to three new staff members: two coordinators, Bethany and Richelle, and a new investigator, Dr Dmitry Samokhin. We’re currently recruiting participants for a new depression clinical trial and have a couple of highlights and new publications to share. In other news, we’ve acquired some extra office space. Our current building will continue to operate as usual. We also hit a major education milestone – over 10,000 students have enrolled in our online courses!
Is knee osteoarthritis keeping you from living your best life? We are looking for people living with knee osteoarthritis to join our new clinical trial.
Ongoing treatment with the investigational product will be provided throughout the study. This will be at no cost to you, and you will be reimbursed for your participation.
View our trials page for more information.
Do you suffer from depressive symptoms? We are currently recruiting participants for a new clinical trial for people living with Depression / Major Depressive Disorder. The trial involves an investigational drug that aims to improve the cognitive symptoms associated with depression, such as memory loss, and difficulty thinking and making decisions.
View our trials page for more information.
Knee osteoarthritis is characterised by bone changes, progressive loss of cartilage, joint space narrowing, and even total joint failure. It causes pain, physical disability, and reduced quality of life. Current treatments include medications, creams, gels, and injections.
We frequently conduct trials involving treatments for osteoarthritis of the knee. Treatments may include oral medications, topical treatments, or injections.
To register your interest for future studies, visit our trials page.
Low back pain is one of the most common types of pain reported by patients and the leading cause of disability worldwide.
We conduct numerous trials for people living with low back pain. Trials may involve injections or medical devices such as spinal cord stimulators. Medical costs are typically covered (no private health insurance is required).
To register your interest for future studies, visit our trials page.
The wonderful Bethany joined our team of Clinical Trial Coordinators earlier this year. She has a Bachelor of Podiatry and is currently completing her Master’s degree in Medical Statistics. During her work as a podiatrist, she witnessed the impact of chronic pain on her patients, particularly those affected by diabetes and arthritis.
Bethany also has experience working on anti-cancer clinical trials as a pharmacy technician. She began working in clinical trials as it enables her to be part of the newest interventions improving people’s quality of life.
Richelle is our newest Clinical Trial Coordinator. Richelle helped us out for a couple of weeks earlier this year and recently joined the team full time!
Richelle is a Registered Midwife with over 8 years’ experience in the maternity sector, including research experience at the Hunter Medical Research Institute where she worked on a large pregnancy study. She is passionate about evidence-based practice and providing culturally safe and inclusive care for all research participants.
We are excited to have Dr Dmitry Samokhin join the Genesis team of investigators! Dr Samokhin is an experienced Medical Practitioner with special interests in anaesthesia, and acute and chronic pain management.
Dr Samokhin works as a CMO Anaesthetist at Maitland Hospital. He is currently working with us on a part-time basis as a dedicated, on-site investigator.
Our amazing Amy is now on maternity leave. We are so excited for her that we held two morning teas in celebration.
While Amy is away, our Clinical Trial Coordinator Emily will be taking on the role of Quality Coordinator.
We wish Amy all the best and can’t wait to meet her little girl!
Well done to the team for meeting another study recruitment target! The study involves an investigational medical device for people living with chronic back and/or leg pain.
Enrollment for this study is now closed, however, if you would like to be notified about future studies for low back pain, you can register your interest here.
Our clinical trial coordinators Bethany and Richelle recently went on an excursion to Lingard Private Hospital to witness their first implant surgery. They were fortunate enough to have the opportunity to watch Dr Volschenk perform an implantation of a spinal cord stimulator for one of our clinical trial participants.
We are extremely grateful to the participant for giving permission to have Bethany and Richelle watch the surgery.
Over 10,000 people have now registered for our online education courses. We are proud to be a popular provider of Good Clinical Practice (ICH GCP) training and glad that we can help people all over the world gain their GCP certification. Learn more about our GCP course here. We also offer a Research Fundamentals training course, which provides a comprehensive introduction to key aspects of clinical trials, including research roles and responsibilities, study design, and understanding clinical trial results. Learn more about the course here. |
To accommodate our growing team and enable us to take on even more studies, we have secured additional office space right across the road. All participants and study visitors will continue to see us at our current building.
The extra office space will allow us to set up additional clinical rooms at our current building and create a more comfortable space for participants to use during longer study visits.
Dr Marc Russo recently co-authored a paper on how we can better assess the outcomes of spinal cord stimulation (SCS) therapy for patients with chronic pain. Traditionally, clinicians have focused on asking patients to record a single pain score to determine if the therapy is helping. But chronic pain impacts people in multiple ways. Patients experience physical disability, emotional distress, and their quality of life is significantly affected.
This paper discusses the need for a “holistic treatment response” to assess the wider impact of chronic pain and consider what matters most to the individual patient.
Dr Russo was honored to be part of a global registry on the safety of spinal cord stimulation. In this large study, patients implanted with a stimulator were followed-up for 3 years and all complications and safety events, including how many patients had their devices taken out (explanted), were recorded.
Over 3 years, there was a low rate of explants and serious complications associated with SCS. Only 7.6% of patients had their devices explanted. The study data also indicate that the safety of SCS devices continues to improve.
View our current studies or register your interest for future trials:
© Genesis Research Services, 2025